Skip to main content
Signal8

Quigley Jill M.

SEC insider (Form 3/4/5 filer). CIK 0001799780. Director at Terns Pharmaceuticals, Inc. (TERN). 16 reported Form 4/5 transactions since Sep 2024; latest on May 5, 2026. Located in FOSTER CITY, CA.

Companies Quigley Jill M. has filed insider reports for

  • Terns Pharmaceuticals, Inc. (TERN): Director
Quigley Jill M. profile photo

Quigley Jill M.

CIK: 0001799780

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (25.0%)

Position reduction

Option Exercises (M)2 (12.5%)

Derivative conversions

Awards (A)3 (18.8%)

Compensation grants

Other (G, F, J, C, D, …)7 (43.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Terns Pharmaceuticals, Inc. logo
TERN

Terns Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (16 total)

  • Terns Pharmaceuticals, Inc. logo
    TERN

    Terns Pharmaceuticals, Inc.

    May 5, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    45K shares-
  • Terns Pharmaceuticals, Inc. logo
    TERN

    Terns Pharmaceuticals, Inc.

    May 5, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    1.7K shares-
  • Terns Pharmaceuticals, Inc. logo
    TERN

    Terns Pharmaceuticals, Inc.

    May 5, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    32K shares-
  • Terns Pharmaceuticals, Inc. logo
    TERN

    Terns Pharmaceuticals, Inc.

    May 5, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    22K shares-
  • Terns Pharmaceuticals, Inc. logo
    TERN

    Terns Pharmaceuticals, Inc.

    May 5, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    4K shares-
  • Terns Pharmaceuticals, Inc. logo
    TERN

    Terns Pharmaceuticals, Inc.

    May 5, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    32K shares-
  • Terns Pharmaceuticals, Inc. logo
    TERN

    Terns Pharmaceuticals, Inc.

    May 5, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    10.7K shares-
  • Terns Pharmaceuticals, Inc. logo
    TERN

    Terns Pharmaceuticals, Inc.

    Feb 1, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    1.7K shares-
  • Terns Pharmaceuticals, Inc. logo
    TERN

    Terns Pharmaceuticals, Inc.

    Nov 4, 2025
    Sale
    Direct
    24.5K shares at avg. $18.00$441K
  • Terns Pharmaceuticals, Inc. logo
    TERN

    Terns Pharmaceuticals, Inc.

    Nov 4, 2025
    Exercise
    Direct
    24.5K shares at avg. $9.24$227K

1-10 of 16